Lunai Bioworks (LNAI) Accumulated Expenses (2012 - 2026)
Lunai Bioworks (LNAI) posted quarterly Accumulated Expenses of $4.9 million for Q1 2026, down 14.05% year-over-year from $5.7 million in Q1 2025, and little changed quarter-over-quarter from $4.9 million in Q4 2025.
Lunai Bioworks (LNAI) Accumulated Expenses (2012 - 2026) Analysis & Trends
Lunai Bioworks' Accumulated Expenses history runs 15 years deep, the most recent figure standing at $4.9 million for Q1 2026.
- In Q1 2026, Accumulated Expenses fell 14.05% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $4.9 million (down 14.05% YoY), while the FY2025 annual figure was $5.8 million, up 10.01% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $4.9 million, roughly flat from $4.9 million in the prior quarter.
- The five-year high for Accumulated Expenses was $5.8 million in Q2 2025, with the low at $466324.0 in Q1 2022.
- The 5-year median for Accumulated Expenses is $3.8 million (2024), against an average of $3.1 million.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses declined 29.89% in 2023, then jumped 634.45% in 2024.
- Lunai Bioworks' Accumulated Expenses stood at $932603.0 in 2022, then declined by 15.98% to $783601.0 in 2023, then jumped by 603.42% to $5.5 million in 2024, then dropped by 10.6% to $4.9 million in 2025, then declined by 0.3% to $4.9 million in 2026.
- Business Quant data shows LNAI's Accumulated Expenses at $4.9 million in Q1 2026, $4.9 million in Q4 2025, and $4.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.91 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Sep 30, 2025 | 4.87 Mn |
| Jun 30, 2025 | 5.84 Mn |
| Mar 31, 2025 | 5.72 Mn |
| Dec 31, 2024 | 5.51 Mn |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 5.31 Mn |
| Mar 31, 2024 | 3.75 Mn |
| Dec 31, 2023 | 783,601.00 |
| Sep 30, 2023 | 797,778.00 |
| Jun 30, 2023 | 723,173.00 |
| Mar 31, 2023 | 593,728.00 |
| Dec 31, 2022 | 932,603.00 |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 466,324.00 |
| Dec 31, 2021 | 504,383.00 |
| Sep 30, 2021 | 364,769.00 |
| Jun 30, 2021 | 1.18 Mn |